Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Novavax Inc Transaction History
Mitsubishi Ufj Kokusai Asset Management Co., Ltd.
- $100 Billion
- Q4 2024
A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Novavax Inc stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 30,389 shares of NVAX stock, worth $214,546. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,389
Previous 17,645
72.22%
Holding current value
$214,546
Previous $222,000
9.91%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding NVAX
# of Institutions
285Shares Held
93.8MCall Options Held
5.4MPut Options Held
8.76M-
Vanguard Group Inc Valley Forge, PA15.7MShares$111 Million0.0% of portfolio
-
Black Rock Inc. New York, NY11.8MShares$83.6 Million0.0% of portfolio
-
Shah Capital Management11.1MShares$78.7 Million35.54% of portfolio
-
State Street Corp Boston, MA7.7MShares$54.4 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY5.79MShares$40.9 Million0.04% of portfolio
About NOVAVAX INC
- Ticker NVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,215,104
- Market Cap $552M
- Description
- Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...